HEMATOLOGICAL AND RENAL FUNCTION PARAMETERS BETWEEN PATIENTS WITH SICKLE CELL ANEMIA AND INDIVIDUALS WITH SICKLE CELL TRAIT
- 1Multiuser Laboratory for Research Support in Nephrology and Medical Sciences (LAMAP), Universidade Federal Fluminense (UFF), Niterói, RJ, Brazil
- 2Hospital Universitário Antônio Pedro (HUAP), Universidade Federal Fluminense (UFF), Niterói, RJ, Brazil
- 3Medical School, Universidade Federal Fluminense (UFF), Niterói, RJ, Brazil
Abstract
Introduction: Sickle cell anemia (SCA) is characterized by homozygosity for hemoglobin S (HbS), chronic hemolysis, vaso-occlusion and multiorgan damage. Renal involvement resulting from these pathological changes is known as sickle cell nephropathy. In contrast, sickle cell trait (SCT), that occurs in heterozygous individuals for HbS, is commonly considered benign. However, emerging evidence suggests that SCT may present subclinical abnormalities, including renal involvement. Objectives: To compare hematological parameters, hemolysis markers, complete blood count (CBC)-derived inflammatory indices and renal markers among individuals with SCA, SCT, and healthy controls. Material and Methods: A cross-sectional observational study included 72 adults (55 with SCA, 6 with SCT, and 11 healthy controls) recruited from the Hematology Outpatient Clinic of the Hospital Universitário Antônio Pedro (HUAP), Universidade Federal Fluminense (UFF), Niterói, RJ, and the university academic community. Assessments included CBC with reticulocyte count, hemolysis markers (lactate dehydrogenase (LDH), total and indirect bilirubin), renal function (serum creatinine and urea, estimated glomerular filtration rate (eGFR), urinary albumin- (uACR) and protein-to-creatinine ratio (uPCR), osmolarity and pH), and CBC-derived inflammatory indices (neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (dNLR), neutrophil-to-platelet ratio (NPR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI)). Group comparisons were performed using one-way ANOVA or the Kruskal-Wallis test with appropriate post-hoc tests. A significance level of 5% was adopted. Results: Red blood cell and hemolysis parameters were similar in SCT and the controls, but differed significantly in SCA (p<.01 for all). Both uACR and uPCR ratio were higher in SCA patients, with no differences between SCT and controls (p<0.0001 for both). Urinary osmolarity and pH were also similar between the SCT and control, differing from SCA (p<0.01 for both). Patients with SCA had higher eGFR than controls, whereas SCT individuals exhibited intermediate values that did not differ from either group (p=0.023). Among inflammatory indices, NPR was significantly higher in SCT and SCA compared controls (p=0.003). SIRI was significantly higher in SCA than in controls, while SCT individuals showed intermediate values without differences from either group (p<0.001). Discussion and Conclusion: Our data suggest that, although the overall hematological profile of individuals with sickle cell trait is comparable to that of the healthy controls, subtle chances in inflammatory and renal function markers may reflect underlying subclinical processes. These findings challenge the traditional view of sickle cell trait as a clinically benign condition, particularly concerning renal function and inflammation. Longitudinal studies with larger cohorts are needed to confirm these associations.
Related
- ECHOCARDIOGRAPHIC PARAMETERS OF PULMONARY HYPERTENSION IN PATIENTS WITH SICKLE CELL ANEMIA: A SYSTEMATIC REVIEW
- Machine Learning Based on Routine Hematological Parameters and Derived Inflammatory Indices for the Diagnosis of Schizophrenia
- Frontal QRS-T angle in patients with Graves’ disease: association with thyroid function and cardiovascular parameters
- Hematological Parameters and Occupational Ionizing Radiation Exposure in Interventional Healthcare Workers: A Longitudinal Matched Case-Control Study.
- A standardized Orthosiphon aristatus extract improves forced-swimming performance and modulates hematological and hepatic biochemical parameters in paclitaxel-treated mice
BibTeX
@article{machado2026hematological,
title = {{HEMATOLOGICAL AND RENAL FUNCTION PARAMETERS BETWEEN PATIENTS WITH SICKLE CELL ANEMIA AND INDIVIDUALS WITH SICKLE CELL TRAIT}},
author = {Vitor Diniz MACHADO and Anderson PAULINO and Daniel Richard MERCANTE and Larissa Camisão AQUINO and Angélica Peçanha DA SILVA and Mariana Correia VIGO and Thalia MEDEIROS and Jocemir Ronaldo LUGON and Guilherme Wataru GOMES},
journal = {Hematology, Transfusion and Cell Therapy},
year = {2026},
month = oct,
doi = {10.1016/j.htct.2026.106655},
url = {https://doi.org/10.1016/j.htct.2026.106655},
note = {CC BY},
}
RIS
TY - JOUR
TI - HEMATOLOGICAL AND RENAL FUNCTION PARAMETERS BETWEEN PATIENTS WITH SICKLE CELL ANEMIA AND INDIVIDUALS WITH SICKLE CELL TRAIT
AU - Vitor Diniz MACHADO
AU - Anderson PAULINO
AU - Daniel Richard MERCANTE
AU - Larissa Camisão AQUINO
AU - Angélica Peçanha DA SILVA
AU - Mariana Correia VIGO
AU - Thalia MEDEIROS
AU - Jocemir Ronaldo LUGON
AU - Guilherme Wataru GOMES
PY - 2026
DA - 2026/10/23
JO - Hematology, Transfusion and Cell Therapy
DO - 10.1016/j.htct.2026.106655
UR - https://doi.org/10.1016/j.htct.2026.106655
AB - Introduction: Sickle cell anemia (SCA) is characterized by homozygosity for hemoglobin S (HbS), chronic hemolysis, vaso-occlusion and multiorgan damage. Renal involvement resulting from these pathological changes is known as sickle cell nephropathy. In contrast, sickle cell trait (SCT), that occurs in heterozygous individuals for HbS, is commonly considered benign. However, emerging evidence suggests that SCT may present subclinical abnormalities, including renal involvement. Objectives: To compare hematological parameters, hemolysis markers, complete blood count (CBC)-derived inflammatory indices and renal markers among individuals with SCA, SCT, and healthy controls. Material and Methods: A cross-sectional observational study included 72 adults (55 with SCA, 6 with SCT, and 11 healthy controls) recruited from the Hematology Outpatient Clinic of the Hospital Universitário Antônio Pedro (HUAP), Universidade Federal Fluminense (UFF), Niterói, RJ, and the university academic community. Assessments included CBC with reticulocyte count, hemolysis markers (lactate dehydrogenase (LDH), total and indirect bilirubin), renal function (serum creatinine and urea, estimated glomerular filtration rate (eGFR), urinary albumin- (uACR) and protein-to-creatinine ratio (uPCR), osmolarity and pH), and CBC-derived inflammatory indices (neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (dNLR), neutrophil-to-platelet ratio (NPR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI)). Group comparisons were performed using one-way ANOVA or the Kruskal-Wallis test with appropriate post-hoc tests. A significance level of 5% was adopted. Results: Red blood cell and hemolysis parameters were similar in SCT and the controls, but differed significantly in SCA (p<.01 for all). Both uACR and uPCR ratio were higher in SCA patients, with no differences between SCT and controls (p<0.0001 for both). Urinary osmolarity and pH were also similar between the SCT and control, differing from SCA (p<0.01 for both). Patients with SCA had higher eGFR than controls, whereas SCT individuals exhibited intermediate values that did not differ from either group (p=0.023). Among inflammatory indices, NPR was significantly higher in SCT and SCA compared controls (p=0.003). SIRI was significantly higher in SCA than in controls, while SCT individuals showed intermediate values without differences from either group (p<0.001). Discussion and Conclusion: Our data suggest that, although the overall hematological profile of individuals with sickle cell trait is comparable to that of the healthy controls, subtle chances in inflammatory and renal function markers may reflect underlying subclinical processes. These findings challenge the traditional view of sickle cell trait as a clinically benign condition, particularly concerning renal function and inflammation. Longitudinal studies with larger cohorts are needed to confirm these associations.
SN - 2531-1379
SN - 2531-1387
ER -